Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- Argonne
- Oak Ridge National Laboratory
- The Ohio State University
- Aarhus University
- Stanford University
- Delft University of Technology (TU Delft)
- EPFL
- King Abdullah University of Science and Technology
- UNIVERSITY OF SYDNEY
- University College Cork
- University of Groningen
- University of North Carolina at Chapel Hill
- University of Oxford
- University of Sydney
- University of Washington
- Aalborg University
- Aston University
- CEA
- CNRS
- Chalmers University of Technology
- Duke University
- Eli Lilly and Company
- Empa
- European Synchrotron Radiation Facility
- FAPESP - São Paulo Research Foundation
- ICN2
- Institute of Photonic Sciences
- Instituto Superior Técnico
- Iowa State University
- KTH Royal Institute of Technology
- Lunds universitet
- Luxembourg Institute of Science and Technology (LIST)
- Massachusetts Institute of Technology
- Max Planck Institute of Molecular Physiology, Dortmund
- NEW YORK UNIVERSITY ABU DHABI
- Northeastern University
- Queen Mary University of London
- Rutgers University
- SUNY University at Buffalo
- Technical University of Munich
- The University of Iowa
- Umeå University
- Universitat Politècnica de València
- Universitat Rovira i Virgili
- Universite de Montpellier
- University of California
- University of Central Florida
- University of Colorado
- University of Lund
- University of Miami
- University of Newcastle
- University of North Texas at Dallas
- University of South Carolina
- University of Texas at Tyler
- University of Warsaw, Faculty of Biology
- Universitätsmedizin Göttingen
- VIB
- 47 more »
- « less
-
Field
-
to projects focused on understanding the molecular and cellular mechanisms underlying metabolic disease, with a particular emphasis on protein trafficking, signalling pathways, membrane transport, proteomics
-
, and receptor–protein interactions within the cell membrane. These investigations aim to reveal how receptor behavior changes in chronic diseases such as heart failure and ischemic cardiomyopathy
-
Conversion Group in the Energy Technologies and Systems Division of the Energy Technologies Area. The work will entail device fabrication, testing and associated diagnostics, component characterization and
-
and lead the development of lithium-ion battery recycling technologies. Develop advanced separation technologies including solvent extraction, membranes, and adsorption, for recycling and purification
-
membrane-based separation operations. Interest in or experience with process analytical technology (PAT) or process intensification. Strong written and oral communication skills; publication and/or
-
fundamental questions. Active areas of research include T cell receptor discovery, membrane-tethered cytokine technologies, tumor resistance mutations, target antigen discovery, and preclinical development
-
engineering. Strong interest in AI-based protein design approaches. Prior research experience in glycoproteins and antibody–antigen interactions. Experience with membrane protein expression and purification
-
endoplasmic reticulum (ER) membrane. The project will combine cutting-edge approaches in functional genomics, mechanistic cell biology, cryo-electron microscopy, and protein engineering. We are particularly
-
Requisition Id 16217 Overview: The Multiscale Biomedical Systems Group within the Advanced Computing in Health (ACH) section of the Computational Sciences and Engineering Division (CSED) at Oak
-
Abilities: Learning Agility: Ability to learn new procedures, technologies, and protocols, and adapt to changing priorities and work demands. Teamwork: Ability to work collaboratively with others and